Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 4Genitourinary 2Thoracic 1Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Dermatologic 1

Conditions

Multiple Myeloma 83Neoplasms, Plasma Cell 54Leukemia 47Precursor Cell Lymphoblastic Leukemia-Lymphoma 45Lymphoma 45Hodgkin Disease 45Myelodysplastic Syndromes 44Lymphoma, Non-Hodgkin 43Leukemia, Myeloid, Acute 43Leukemia, Lymphocytic, Chronic, B-Cell 43Lymphoma, Follicular 35Lymphoma, Large B-Cell, Diffuse 34Lymphoma, Mantle-Cell 32Lymphoma, B-Cell, Marginal Zone 32Lymphoma, Large-Cell, Immunoblastic 31Leukemia, Myeloid, Chronic-Phase 30Congenital Abnormalities 30Burkitt Lymphoma 30Primary Myelofibrosis 27Myeloproliferative Disorders 27Leukemia, Myeloid, Accelerated Phase 27Leukemia, Myelomonocytic, Chronic 24Blast Crisis 24Recurrence 21Lymphoma, T-Cell, Cutaneous 18Dendritic Cell Sarcoma, Interdigitating 18Waldenstrom Macroglobulinemia 17Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 17Myelodysplastic-Myeloproliferative Diseases 16Pdgfra-Associated Chronic Eosinophilic Leukemia 14

Interventions

Cyclophosphamide 8Zoledronic Acid 5Therapeutics 5Flow Cytometry 5pembrolizumab 3fludarabine 3Specimen Handling 3Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Immunologic Techniques 3Gemcitabine 3Amplified Fragment Length Polymorphism Analysis 3venetoclax 2trametinib 2ruxolitinib 2pertuzumab 2palbociclib 2liposomal doxorubicin 2liposomal amphotericin B 2dabrafenib 2copanlisib 2aldesleukin 2abiraterone 2Vorinostat 2Trastuzumab 2Surveys and Questionnaires 2Sunitinib 2Sorafenib 2Rituximab 2Psychiatric Rehabilitation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × Busulfan × Plasma cell × Clear all
NCT00060255 2013-05-09

High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors

Roswell Park Cancer Institute

Phase 2 Completed
451 enrolled
BreastGenitourinaryLymphoidOther hematologic neoplasmPlasma cellSarcoma

Testicular Germ Cell Tumor, Congenital Abnormalities, Immunoglobulin Light-chain Amyloidosis, Blast Crisis, Breast Neoplasms, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Recurrence, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Breast Neoplasms, Male, Lymphoma, Mantle-Cell, Neoplasms, Plasma Cell, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡